Electromed develops, manufactures, and sells the SmartVest Airway Clearance System, a high-frequency chest wall oscillation device used primarily in home settings to assist patients with impaired airway clearance. The products target individuals with conditions such as bronchiectasis and other chronic respiratory issues, with the company managing referrals, insurance reimbursement, delivery, and training through a direct-to-patient model. Devices are designed for comfort, portability, and ease of use, with manufacturing located in the United States.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 15.7 | — | 1.9 | 29.3% |
| Q2 2025 | 17.4 | — | 2.2 | 27.3% |
| Q3 2025 | 16.9 | — | 2.1 | 54.5% |
| Q4 2025 | 18.9 | — | 2.8 | 48.4% |
| Q1 2026 | 18.6 | 18.4% | 3 | 58.8% |
| Q2 2026 | 19.4 | 11.6% | 3.4 | 54.3% |
All markets — KeepWinning global stock screener
Other companies on NYSE American: Exodus Movement, Inc. (EXOD), Titan Mining Corporation (TII), Silver Bow Mining Corp. (SBMT), Rare Earths Americas, Inc. (REA), Protalix BioTherapeutics, Inc. (PLX), Energy Transfer LP (ET)